| Filed On | Filing |
|---|---|
| 13 Oct 2026 | EFFECT |
| 09 Oct 2026 | S-8 |
| 06 Oct 2026 |
8-K: Regulation FD Disclosure
August orders increase 16.4%, while estimated backlog grows 145.1% to approximately $898,000. Preliminary net sales reach $2.34 million, extending the Company’s eight-month sales climb |
| 05 Oct 2026 | S-3 |
| 04 Sep 2026 | 8-K: Submission of Matters to a Vote of Security Holders |
| 27 Aug 2026 | 8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities |
| 26 Aug 2026 | 8-K: Regulation FD Disclosure |
| 14 Aug 2026 | 8-K: Notice of Delisting or Failure to Satisfy a Listing Rule |
| 11 Aug 2026 | FORM 10-Q |
| 11 Aug 2026 | 8-K: Regulation FD Disclosure |
| 07 Aug 2026 | 424B5 |
| 31 Jul 2026 |
Form 4: Kartychak Jennifer Anne, Chief Financial Officer
Received 143,000 shares by exercise or conversion |
| 29 Jul 2026 | 8-K: Regulation FD Disclosure |
| 28 Jul 2026 |
8-K/A: Results of Operations and Financial Condition; Regulation FD Disclosure
Net sales increase 46%, while gross profit materially outpaces top-line growth, Company materially closer to cash-flow breakeven. |
| 22 Jul 2026 | 8-K: Regulation FD Disclosure |
| 20 Jul 2026 | Proxy statement: annual meeting on September 3, 2026 |
| 15 Jul 2026 | PRER14A |
| 10 Jul 2026 |
Form 4: Kartychak Jennifer Anne, Chief Financial Officer
Received 6,104 shares as a grant or award ($7.02K) |
| 10 Jul 2026 | PRE 14A |
| 25 Jun 2026 | 8-K: Regulation FD Disclosure |
Loading...
